Soltis Investment Advisors LLC

Position in VRTX — Vertex Pharmaceuticals Inc / Ma

CIK 1802530 ST. GEORGE, UT

Position in VRTX

as of Jun 30, 2026 · filed Jul 31, 2026 Compact

Position Value

$543,422

+$115,191 QoQ

Shares Held

1,094

+14.1% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.05%

of 13F equity value

Holder Rank

#1,046

of 1,746 holders

Holding Since

Mar 2022

11 quarters on record

Voting authority Sole 71% Shared 0% None 29%

Healthcare · as of Jun 30, 2026

Soltis Investment Advisors LLC holds $1,389,119 across 4 Biotechnology names. VRTX ranks #1 (39.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma This page	1,094	$543,422
2	REGN	Regeneron Pharmaceuticals, Inc.	810	$505,067
3	EXEL	Exelixis, Inc.	4,548	$247,456
4	LXEO	Lexeo Therapeutics, Inc.	20,016	$93,174

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$543,422	1,094	+14.1%	Shares	Sole	2026-07-31
2026-03-31	$428,231	959	+9.7%	Shares	Sole	2026-04-27
2025-12-31	$396,236	874	+15.3%	Shares	Sole	2026-04-02
2025-09-30	$296,863	758	-4.8%	Shares	Sole	2025-11-12
2025-06-30	$354,379	796	-10.1%	Shares	Sole	2025-08-06
2025-03-31	$429,065	885	+16.1%	Shares	Sole	2025-05-13
2024-12-31	$306,857	762	-2.1%	Shares	Sole	2025-01-29
2024-09-30	$361,832	778	+11.9%	Shares	Sole	2025-01-03
2024-06-30	$325,760	695	-90.3%	Shares	Sole	2024-08-12
2022-06-30	$2,025,506	7,188	+6.5%	Shares	Sole	2022-08-11
2022-03-31	$1,760,764	6,747	—	Shares	Sole	2022-05-06
No filing history on record for this holder in this stock.